Bone Health

Immunology

Hematology

Respiratory

Dermatology

Diabetes

Gastroenterology

Neurology

Oncology

Ophthalmology

Rare Disease

Rheumatology

News

Media

All Videos

Insights

Interviews

Peer Exchange

Podcasts

Compendia

Conferences

Conference Coverage

Conference Listing

CME/CE

Resources

Authors

Biosimilar Resources

Interactive Tools

WHEN CHOICE ARRIVES: Competition & Consequences

Subscribe

E-News

Print Subscription

BIOSIMILAR APPROVALS

Videos

Here are the top 5 biosimilar articles for the week of May 29, 2023.

The Top 5 Biosimilar Articles for the Week of May 29

Articles

The Mark Cuban Cost Plus Drug Company, an online pharmacy dedicated to increasing access to lower-cost prescriptions, is partnering with Coherus Biosciences to distribute Yusimry, a biosimilar referencing Humira. It’s the first time the pharmacy has added a biosimilar to its list of drugs.

Mark Cuban’s Online Pharmacy Partners With Coherus Biosciences for Humira Biosimilar

Over the course of May, the immunology biosimilar space bloomed, with a European approval, a delay for ustekinumab biosimilars, more clinical trial updates, and insights into the industry from multiple immunology experts.

Biosimilars Immunology Roundup: May 2023

The European Commission has granted marketing authorization to the first biosimilar referencing Soliris (eculizumab). The product, dubbed Epysqli, was developed by Samsung Bioepis and is the first hematology biosimilar from the company to be approved in the European Union.

First Eculizumab Biosimilar Approved in Europe

About

Contact

Advisory Board

Do Not Sell My Information

Terms & Conditions

Privacy Policy

Center for Biosimilars®

Facebook

Twitter

LinkedIn

Business Practice

Business

Development

Legal

Policy

Practice

Regulatory

The Center for Biosimilars
2 Clarke Drive, Suite 100
Cranbury, NJ 08512

1rem

Contact Us

Contact Us

The Center for Biosimilars2 Clarke Drive, Suite 100Cranbury, NJ 08512

Editorial Staff

The Center for Biosimilars
2 Clarke Drive, Suite 100
Cranbury, NJ 08512